![conference banner](/images/conference-banner.jpeg)
Abstract
Background: Colorectal cancer is the third most commonly diagnosed cancer in the world, causing many deaths every year. Combined chemotherapy has opened a new horizon in treating colorectal cancer. The objective of the present study is to investigate the activity of oxaliplatin in combination with emetine and patulin against colorectal cancer models.
Methods: IC50 values of oxaliplatin, emetine and patulin were determined against human colorectal cancer cell lines (HT-29 and Caco-2) using MTT reduction assay. Synergistic, antagonistic and additive effects from the selected binary combinations were determined as a factor of sequence of administration and added concentrations. Proteomics was carried out to identify the proteins which were accountable for combined drug action applying to the selected drug combination.
Results: Oxaliplatin in combination with patulin produced synergism against human colorectal cancer models depending on dose and sequence of drug administration. Bolus administration of oxaliplatin with patulin proved to be the best in terms of synergistic outcome. Altered expressions of nine proteins (ACTG, PROF1, PPIA, PDIA3, COF1, GSTP1, ALDOA, TBA1C and TBB5) were considered for combined drug actions of oxaliplatin with patulin.
Conclusion: Bolus administration of oxaliplatin with patulin has the potential to be used in the treatment of colorectal cancer, and would warrant further evaluation using suitable animal model.
Keywords: Emetine, patulin, colorectal cancer, synergism, oxaliplatin, MTT.
[PMID: 28870954]
[http://dx.doi.org/10.18632/oncotarget.19887] [PMID: 29029506]
(b) Bhattacharya, S.; Muhammad, N.; Steele, R.; Kornbluth, J.; Ray, R.B. Bitter melon enhances natural killer-mediated toxicity against head and neck cancer cells. Cancer Prev. Res. (Phila.), 2017, 10(6), 337-344.
[http://dx.doi.org/10.1158/1940-6207.CAPR-17-0046] [PMID: 28465362]
(c) Bhattacharya, S.; Muhammad, N.; Steele, R.; Peng, G.; Ray, R.B. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth. Oncotarget, 2016, 7(22), 33202-33209.
[http://dx.doi.org/10.18632/oncotarget.8898] [PMID: 27120805]
[http://dx.doi.org/10.1038/srep11853] [PMID: 26149967]
(b) Mohammad, N.; Malvi, P.; Meena, A.S.; Singh, S.V.; Chaube, B.; Vannuruswamy, G.; Kulkarni, M.J.; Bhat, M.K. Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma. Mol. Cancer, 2014, 13(1), 204.
[http://dx.doi.org/10.1186/1476-4598-13-204] [PMID: 25178635]
[PMID: 22110201]
(b) Yunos, N.M.; Beale, P.; Yu, J.Q.; Huq, F. Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells. Anticancer Res., 2011, 31(4), 1131-1140.
[PMID: 21508356]
(c) Nessa, M.U.; Beale, P.; Chan, C.; Yu, J.Q.; Huq, F. Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells. Anticancer Res., 2012, 32(1), 53-59.
[PMID: 22213288]
(d) Arzuman, L.; Beale, P.; Yu, J.Q.; Huq, F. Synthesis of tris(quinoline)monochloroplatinum(II) chloride and its activity alone and in combination with capsaicin and curcumin in human ovarian cancer cell lines. Anticancer Res., 2016, 36(6), 2809-2818.
[PMID: 27272792]
[http://dx.doi.org/10.1002/1097-0142(197104)27:4<835:AID-CNCR2820270413>3.0.CO;2-K] [PMID: 4929936]
(b) Kane, R.C.; Cohen, M.H.; Broder, L.E.; Bull, M.I.; Creaven, P.J.; Fossieck, B.E., Jr Phase I-II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma. Cancer Chemother. Rep., 1975, 59(6), 1171-1172.
[PMID: 1222395]
[http://dx.doi.org/10.1093/toxsci/kfu319] [PMID: 25577197]
(b) Abastabar, M.; Akbari, A.; Akhtari, J.; Hedayati, M.T.; Shokohi, T.; Mehrad-Majd, H.; Ghalehnoei, H.; Ghasemi, S. In vitro antitumor activity of patulin on cervical and colorectal cancer cell lines. Curr Med Mycol, 2017, 3(1), 25.
[http://dx.doi.org/10.29252/cmm.3.1.25]]
(c) Boussabbeh, M.; Ben Salem, I.; Rjiba-Touati, K.; Bouyahya, C.; Neffati, F.; Najjar, M.F.; Bacha, H.; Abid-Essefi, S. The potential effect of patulin on mice bearing melanoma cells: an anti-tumour or carcinogenic effect? Tumour Biol., 2016, 37(5), 6285-6295.
[http://dx.doi.org/10.1007/s13277-015-4474-z] [PMID: 26619846]
[http://dx.doi.org/10.1016/0022-1759(83)90303-4] [PMID: 6606682]
[http://dx.doi.org/10.1016/0065-2571(84)90007-4] [PMID: 6382953]
[http://dx.doi.org/10.1186/s12885-016-2731-1] [PMID: 27566066]
[http://dx.doi.org/10.1016/j.toxicon.2015.03.004] [PMID: 25772858]
(b) Zouaoui, N.; Mallebrera, B.; Berrada, H.; Abid-Essefi, S.; Bacha, H.; Ruiz, M-J. Cytotoxic effects induced by patulin, sterigmatocystin and beauvericin on CHO-K1 cells. Food Chem. Toxicol., 2016, 89, 92-103.
[http://dx.doi.org/10.1016/j.fct.2016.01.010] [PMID: 26802678]
[http://dx.doi.org/10.1007/s00280-009-0997-6] [PMID: 19381631]
[http://dx.doi.org/10.1016/j.toxicon.2014.12.002] [PMID: 25478806]
[http://dx.doi.org/10.1016/j.cellsig.2011.12.017] [PMID: 22230687]
[http://dx.doi.org/10.1242/jcs.041970] [PMID: 19638415]
[http://dx.doi.org/10.1096/fj.11-185447] [PMID: 21908715]
[http://dx.doi.org/10.1016/j.cancergencyto.2010.01.003] [PMID: 20362224]
[http://dx.doi.org/10.3748/wjg.v20.i18.5511] [PMID: 24833881]
[http://dx.doi.org/10.1002/cm.21096] [PMID: 23335583]
[http://dx.doi.org/10.1016/0092-8674(93)90527-W] [PMID: 8252619]
[http://dx.doi.org/10.1074/mcp.M111.009449]
[http://dx.doi.org/10.1111/jop.12523] [PMID: 27862305]
[http://dx.doi.org/10.1084/jem.191.10.1675] [PMID: 10811861]
[http://dx.doi.org/10.1186/1476-4598-13-187] [PMID: 25103363]
[http://dx.doi.org/10.1111/j.1442-2042.2010.02670.x] [PMID: 21091798]
[http://dx.doi.org/10.3748/wjg.v21.i8.2323] [PMID: 25741138]
[http://dx.doi.org/10.1016/j.jprot.2016.12.004] [PMID: 27986506]
[http://dx.doi.org/10.2174/1568026033451899] [PMID: 12871171]
[PMID: 19865066]
[http://dx.doi.org/10.1016/j.jss.2004.08.026] [PMID: 15680395]
[PMID: 12670919]
[http://dx.doi.org/10.1006/bbrc.2002.6547] [PMID: 11866469]
[http://dx.doi.org/10.3892/ijo.30.4.849] [PMID: 17332923]
[http://dx.doi.org/10.1186/1756-9966-29-97] [PMID: 20637127]
[http://dx.doi.org/10.1074/mcp.M700544-MCP200] [PMID: 18421009]
[http://dx.doi.org/10.1021/pr800174k] [PMID: 18698805]
[http://dx.doi.org/10.1002/jcb.21727] [PMID: 18320592]
[http://dx.doi.org/10.1016/j.immuni.2008.10.018] [PMID: 19119025]
[http://dx.doi.org/10.4238/2015.June.26.4] [PMID: 26125904]
[http://dx.doi.org/10.1155/2016/4518281]
[http://dx.doi.org/10.1074/jbc.M114.619353] [PMID: 25697356]
[http://dx.doi.org/10.1038/nrc2148] [PMID: 17522712]
[http://dx.doi.org/10.1016/j.bbamcr.2006.07.001] [PMID: 16926057]
[http://dx.doi.org/10.1016/j.tcb.2010.01.001] [PMID: 20133134]
[http://dx.doi.org/10.1038/sj.emboj.7601852] [PMID: 17853892]
[http://dx.doi.org/10.1002/1098-1136(200011)32:2<146:AID-GLIA40>3.0.CO;2-3] [PMID: 11008214]
[http://dx.doi.org/10.1021/pr050455t] [PMID: 16674103]
[http://dx.doi.org/10.1002/(SICI)1522-2683(19991001)20:14<2952:AID-ELPS2952>3.0.CO;2-H] [PMID: 10546833]
[http://dx.doi.org/10.1016/j.bbapap.2006.09.014] [PMID: 17085086]
[http://dx.doi.org/10.1002/elps.200500510] [PMID: 16568407]
[http://dx.doi.org/10.1002/pmic.200300464] [PMID: 12923786]
[http://dx.doi.org/10.1007/BF03402191] [PMID: 11071270]
[http://dx.doi.org/10.1007/s00280-014-2566-x] [PMID: 25143300]
[http://dx.doi.org/10.1038/cdd.2010.80] [PMID: 20596078]
[http://dx.doi.org/10.1371/journal.pone.0085804] [PMID: 24465716]
[http://dx.doi.org/10.1016/j.canlet.2016.01.054] [PMID: 26854714]
(b) Peng, Y.; Li, X.; Wu, M.; Yang, J.; Liu, M.; Zhang, W.; Xiang, B.; Wang, X.; Li, X.; Li, G.; Shen, S. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer. Mol. Biosyst., 2012, 8(11), 3077-3088.
[http://dx.doi.org/10.1039/c2mb25286d] [PMID: 22996014]
[http://dx.doi.org/10.7124/bc.00092F]
[http://dx.doi.org/10.1016/j.tox.2008.03.019] [PMID: 18495319]
[PMID: 22399603]
(b) Kruger, S.; Abd Elmageed, Z.Y.; Hawke, D.H.; Wörner, P.M.; Jansen, D.A.; Abdel-Mageed, A.B.; Alt, E.U.; Izadpanah, R. Molecular characterization of exosome-like vesicles from breast cancer cells. BMC Cancer, 2014, 14(1), 44.
[http://dx.doi.org/10.1186/1471-2407-14-44] [PMID: 24468161]
[http://dx.doi.org/10.1038/nrc2803] [PMID: 20147901]
[http://dx.doi.org/10.1016/j.compbiolchem.2015.02.018] [PMID: 25854803]
[http://dx.doi.org/10.1093/jnci/93.24.1886] [PMID: 11752014]
![Wayfinder Image](/images/wayfinder.jpg)